The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss

British Journal of Haematology

Volumn 105, Issue 1, 1999, Pages 98-101

  Holmes, Zandra R ^a,d   Regan, Lesley ^a   Chilcott, Ian ^b   Cohen, Hannah ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

MTHFR; Recurrent miscarriage

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FETUS WASTAGE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); MIDDLE AGED; MUTATION; PREGNANCY; RISK FACTORS;

EID: 0032891393     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01319.x     Document Type: Article

References (20)

1. Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, ER., Dirven, R.J., de Ronde, IL. van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
2. Bokarewa, M.I., Bremme, K. & Blomback. M. (1996) Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy. British Journal of Haematology. 92, 473-478.
3. Dahlback, B., Carlsson. M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
4. Dekker, G.A., de Vries, J.I.P., Doelitzsch, P.M., Huijgens, P.C., ven Blomberg, B.M.E., Jakobs, C. & van Geijn, H.P. (1995) Underlying disorders associated with severe early-onset preeclampsia. American Journal of Obstetrics and Gynecology. 173, 1042-1048.
5. Den Heijer, M., Blom, H.J., Gerrits, W.B.J., Rosendaal. F.R., Haak, H.L., Wijermans, P.W. & Bos, H.M.J. (1995) Is hyperhomocysteinaetnia a risk factor for recurrent venous thrombosis? Lancet, 345, 882-885.
6. Den Heijer. M., Koster, T., Blom, HJ., Bos, G.M.J., Briet, E., Reitsma, P.H., Vandenbroucke, J. & Rosendaal, ER. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334, 759-762.
7. De Vries, J.I.P., Dekker, G.A., Huijens. P.C., Jakobs. C., Blomberg, B.M.E. & van Geijn. H.P. (1997) Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. British Journal of Obstetrics and Gynaecology, 104, 1248-1254.
8. Franco, R.F., Araujo, A.G., Guerreiro, J.F., FJion, J. & Zago, M.A. (1998) Analysis of the 677 CT mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thrombosis and Haemostasis. 79, 119-121.
9. Freyburger, G:, Lubrouche, S., Sassoust, G., Rouanet, E, Javorschi, S. & Parrot, F. (1997) Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thrombosis and Haemostasis, 77, 466-471.
10. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard. C.A., Matthews, R.G., Boers, G.J.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuvel, L.P. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nature Genetics. 10, 111-113.
11. Grandone, E., Margaglione, M., Colaizzo, D., d'Addedda, M., Cappucci, G., Vecchione, G., Scianname, N., Pavone, G. & Di Minno, G. (1997) Factor V Leiden is associated with repeated and recurrent fetal losses. Thrombosis and Haemostasis. 77, 822-824.
12. Jacques. P.P., Bostom, A.G., Williams, R.R., Ellison, R.C., Eckfeldt, J.H., Rosenberg, I.H., Selhub, J. & Rozen. R. (1996) Relationship between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation, 93, 7-9.
13. Nelen. W.L.D.M., Steegers, E.A.P., Eskes, T.K.A.B. & Blom, H.J. (1997) Genetic risk factor for unexplained recurrent early pregnancy loss. lancet. 350. 861.
14. Preston, P.E., Rosendaal. F.R., Walker, I.D., Briet, E., Berntorp, E., Conard, ]., Fontecuberta, J., Makris, M., Mariant, G., Notenoom, W, Pabinger, L, Legnani, C Scharrer, L, Schulman, S. & van der Meer, F.J.M. (1996) Increased fetal loss in women with heritable thrombophilia. lancet, 348. 913-916.
15. Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal. 314, 253-257.
16. Rai, R., Regan, L., Hadley, E., Dave, M. & Cohen. H. (1996) Second-trimester pregnancy loss is associated with activated protein C resistance. British Journal of Haematology, 92, 489-490.
17. Rees, M.M. & Rodgers, G.M. (1993) Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thrombosis Research, 71, 337-359.
18. Sanson, B.-J., Friederich, P.W., Simioni. P., Zanardi. S., Huisman, M.V., Girolami, A., ten Cate. J.-W. & Prins. M.H. (1996) The risk of abortion and stillbirth in antithrombin-, protein C- and protein S-deficient women. Thrombosis anil Ilaemostasis, 75, 387-388.
19. Steegers-Theunissen, R.P.M., Boers, G.H.J., Trijbels, J.M.F. & Eskes, T.K.A.B. (1990) Neural-tube defects and derangement of homocysteine metabolism. (Letter). New England Journal of Medicine, 324, 199-200.
20. Wouters, M.G.A.J., Thomas, C.M.G., Boers. G.Ei.J., Borm, G.F., Blom. H.J., Steegers-Theunissen, R.P.M., Trijbels, F.J.M. & Eskes. T.KA.B. (1993) Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertility and Sterility. 60, 820-825.